MEDICURE INC
Close on Oct 19, 2026
About Medicure
Pharmaceutical Preparations, SIC 2834
Medicure Inc. is a pharmaceutical company that develops, commercializes, and distributes healthcare products primarily focused on cardiovascular therapeutics and retail pharmacy operations. Its marketed product portfolio includes cardiovascular medications such as AGGRASTAT and ZYPITAMAG, alongside an expanding pharmacy business segment comprising Marley Drug, Gateway Pharmacy, and West Olympia Pharmacy. The company supplies generic and specialty pharmaceuticals directly to patients, offering mail-order delivery without requiring insurance. Medicure serves a customer base consisting of drug wholesalers, hospital health systems, prescribers, and direct-to-consumer retail patients.
The company conducts its commercial and pharmaceutical distribution activities across the United States and its territories, delivering prescription medications to consumers in all 50 states, Washington, D.C., and Puerto Rico. Its physical pharmacy operations include retail storefronts located in Portland, Oregon and Olympia, Washington, and it coordinates clinical trials in the United States and Australia. Medicure is headquartered at its registered office in Winnipeg, Manitoba, Canada.
Summary of the business section of Medicure's latest annual report, written by StockData.
Company profile
Company
- Legal name
- MEDICURE INC
- Founded
- 1999
- Headquarters
- Winnipeg, Manitoba, Canada
- Address
- Suite 2, 1250 Waverley Street R2C 0A1
- Phone
- (204) 487-7412
- Website
- marleydrug.com
- Employees
- 22, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- A2
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Winnipeg, Canada
Stock & identifiers
- Ticker
- MCUJF
- Exchange
- OTC
- Shares outstanding
- 10M, Dec 31, 2025
- Filer category
- Non-accelerated filer
- Stock splits
- 1-for-15 reverse, Nov 2, 2012
- SEC CIK
- 1133519
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Medicure's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“Directors and Senior Management of this item, the Company has 22 employees through Medicure as at December 31, 2025.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 1, 2018 | Late filing | Notification of late filing |
| Jul 3, 2008 | Delisting | Notice of delisting from exchange (Form 25) |
| Feb 12, 2004 | Listing | Registration of securities on an exchange (Form 8-A) |